Insider · CIK 0001769668

Kelly Michael Aaron

Reports to the SEC for 6 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001769668

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+75K sh	—	—	75,000
2026-06-01	NEONEOGENOMICS INCM Exercise/Conversion	Director	MExercise/Conversion	+23.1K sh	—	—	67,086
2026-06-01	NEONEOGENOMICS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−23.1K sh	—	—	0
2026-06-01	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+11.1K sh	—	—	11,069
2026-06-01	NEONEOGENOMICS INC · Restricted Stock UnitA Award	Director	AAward	+16K sh	—	—	15,970
2026-05-13	BOOMDMC Global Inc.A Award	Director	AAward	+16.9K sh	—	—	65,590
2026-04-27	AMICUS THERAPEUTICS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−72.5K sh	$14.50	−$1.05M	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−36.1K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45.4K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30.5K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−42.5K sh	—	—	0
2026-04-27	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−74.9K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.5K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,510
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,006 sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,006 sh	—	—	9,006
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−39.1K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+39.1K sh	—	—	39,062
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−45K sh	—	—	0
2025-08-01	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2025-06-05	AMICUS THERAPEUTICS, INC.A Award	Director	AAward	+20.4K sh	—	—	72,468
2025-06-05	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Director	AAward	+74.9K sh	—	—	74,872
2025-06-04	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+55K sh	—	—	55,000
2025-06-01	NEONEOGENOMICS INCM Exercise/Conversion	Director	MExercise/Conversion	+12.3K sh	—	—	44,009
2025-06-01	NEONEOGENOMICS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−12.3K sh	—	—	0
2025-06-01	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+16.1K sh	—	—	16,107
2025-06-01	NEONEOGENOMICS INC · Restricted Stock UnitA Award	Director	AAward	+23.1K sh	—	—	23,077
2025-05-27	NEONEOGENOMICS INCP Purchase	Director	PPurchase	+5,000 sh	$7.60	+$38K	5,000
2025-05-14	BOOMDMC Global Inc.A Award	Director	AAward	+17.6K sh	—	—	48,653
2025-02-26	BOOMDMC Global Inc.A Award	Director	AAward	+5,518 sh	—	—	31,073
2024-08-10	NEONEOGENOMICS INCM Exercise/Conversion	Director	MExercise/Conversion	+11.3K sh	—	—	31,755
2024-08-10	NEONEOGENOMICS INC · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−11.3K sh	—	—	0
2024-06-12	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	45,000
2024-06-06	AMICUS THERAPEUTICS, INC.A Award	Director	AAward	+11.8K sh	—	—	52,054
2024-06-06	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Director	AAward	+42.5K sh	—	—	42,467
2024-06-01	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+8,672 sh	—	—	8,672
2024-06-01	NEONEOGENOMICS INC · Restricted Stock UnitA Award	Director	AAward	+12.3K sh	—	—	12,254
2024-05-15	BOOMDMC Global Inc.A Award	Director	AAward	+9,520 sh	—	—	25,555
2023-08-10	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+8,353 sh	—	—	8,353
2023-08-10	NEONEOGENOMICS INC · Restricted Stock UnitA Award	Director	AAward	+11.3K sh	—	—	11,336
2023-06-14	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+39.1K sh	—	—	39,062
2023-06-08	AMICUS THERAPEUTICS, INC.A Award	Director	AAward	+8,584 sh	—	—	40,207
2023-06-08	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Director	AAward	+30.5K sh	—	—	30,474
2023-05-10	BOOMDMC Global Inc.A Award	Director	AAward	+7,086 sh	—	—	16,035
2022-10-19	PRMEPrime Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,006 sh	—	—	9,006
2022-06-30	HOOKHOOKIPA Pharma Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-06-10	NEONEOGENOMICS INCA Award	Director	AAward	+15.6K sh	—	—	20,419
2022-06-10	NEONEOGENOMICS INC · Stock Option (Right to Buy)A Award	Director	AAward	+13.9K sh	—	—	13,882
2022-06-09	AMICUS THERAPEUTICS, INC.A Award	Director	AAward	+12.7K sh	—	—	31,623
2022-06-09	AMICUS THERAPEUTICS, INC.Stock Options (right to buy)A Award	Director	AAward	+45.4K sh	—	—	45,423

Recent filings

Accepted (ET)
Jun 84
Kelly Michael Aaron0001628280-26-041569
SEC(opens sec.gov)
Jun 34
Kelly Michael Aaron0001628280-26-040574
SEC(opens sec.gov)
May 144
Kelly Michael Aaron0001769668-26-000002
SEC(opens sec.gov)
Apr 274
Kelly Michael Aaron0001193125-26-182271
SEC(opens sec.gov)
Aug 54
Kelly Michael Aaron0001894562-25-000047
SEC(opens sec.gov)

Companies

Address

C/O PRIME MEDICINE, INC. 60 FIRST STREET

CAMBRIDGE, MA, 02141